NDT Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Stock Symbol
  • NDTP

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.11
  • (As of Friday Closing)

NDT Pharmaceuticals General Information

Description

NDT Pharmaceuticals Inc is a biotechnology company focused on consumer health and wellness solutions. The company is engaged in promoting vitality through eco-friendly, nature-derived products that support healthier living environments. The company offers safe and effective solutions for home, pet, personal care, and animal health.

Contact Information

Formerly Known As
Mistral Ventures, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 8400 Old Courthouse Road
  • Vienna, VA 22182
  • United States
+1 (315)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Corporate Office
  • 8400 Old Courthouse Road
  • Vienna, VA 22182
  • United States
+1 (315)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NDT Pharmaceuticals Stock Performance

As of 13-Nov-2026, NDT Pharmaceuticals’s stock price is $0.11. Its current market cap is $21M with 197M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.08 $0.01 - $2.10 $21M 197M 79.7K

NDT Pharmaceuticals Financials Summary

As of 30-Jun-2008, NDT Pharmaceuticals has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2008 FY 2007 31-Dec-2007 FY 2006 31-Dec-2006 FY 2005 31-Dec-2005
EV 42,932
Revenue 0
Net Income (1,229) (1,037) (52) (6)
Total Assets 0 109 78 9
Total Debt 158 101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NDT Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NDT Pharmaceuticals‘s full profile, request access.

Request a free trial

NDT Pharmaceuticals Investments & Acquisitions (4)

NDT Pharmaceuticals’s most recent deal was a Merger/Acquisition with ByoPlanet. The deal was made on 05-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ByoPlanet 05-Sep-2025 Merger/Acquisition Other Commercial Products
Axle (Business/Productivity Software) 21-Jun-2024 Seed Round Business/Productivity Software
Wisk.ai 08-Jun-2018 Seed Round Business/Productivity Software
Nature's Bioceuticals 20-Oct-2011 Reverse Merger Food Products
To view NDT Pharmaceuticals’s complete investments and acquisitions history, request access »

NDT Pharmaceuticals FAQs

  • When was NDT Pharmaceuticals founded?

    NDT Pharmaceuticals was founded in 2005.

  • Where is NDT Pharmaceuticals headquartered?

    NDT Pharmaceuticals is headquartered in Vienna, VA.

  • What industry is NDT Pharmaceuticals in?

    NDT Pharmaceuticals’s primary industry is Biotechnology.

  • Is NDT Pharmaceuticals a private or public company?

    NDT Pharmaceuticals is a Public company.

  • What is NDT Pharmaceuticals’s stock symbol?

    The ticker symbol for NDT Pharmaceuticals is NDTP.

  • What is the current stock price of NDT Pharmaceuticals?

    As of 13-Nov-2026 the stock price of NDT Pharmaceuticals is $0.11.

  • What is the current market cap of NDT Pharmaceuticals?

    The current market capitalization of NDT Pharmaceuticals is $21M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process